J&J | Себестоимость



Cost Of Sales Изменить Дата
AbbVie USD 4.4B 184M 2024-12
Abbott USD 4.94B 246M 2024-12
Amgen USD 3.11B 198M 2024-12
AstraZeneca USD 2.72B 263M 2024-12
Baxter International USD 1.74B 73M 2024-12
Bayer EUR 5.72B 633M 2024-12
Becton, Dickinson and Co. USD 2.93B 21M 2024-12
Biogen USD 583.5M 55.2M 2024-12
Boston Scientific USD 1.46B 158M 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
CONMED USD 147.6M 9.89M 2024-12
Cooper Companies USD 304.5M 36.2M 2025-01
Dexcom USD 404.2M 3.8M 2024-12
Edwards Lifesciences USD 292.2M 29.3M 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
Globus Medical USD 263.44M 7.08M 2024-12
Hologic USD 441.3M 11M 2024-12
Indivior 59M 7M 2024-09
Insulet USD 166.6M 200K 2024-12
Integra LifeSciences USD 176.8M 14.01M 2024-12
Intuitive Surgical USD 771.3M 107.1M 2024-12
J&J USD 7.11B 151M 2024-12
Medtronic USD 2.78B 160M 2025-01
Merck USD 3.71B 181M 2024-12
Merit Medical Systems USD 182.18M 135K 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 5.65B 781M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 4.08B 675M 2024-09
Stryker USD 2.24B 261M 2024-12
Tandem Diabetes Care USD 125.19M 5.88M 2024-12
Teva Pharmaceutical Industries USD 2.11B 18M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Zimmer Biomet Holdings USD 586.7M 48.1M 2024-12
Zoetis USD 707M 8M 2024-12



J&J Себестоимость - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2025.